Nurix Therapeutics, Inc.
NRIXNasdaqCIK 1549595HealthcareFiscal year ends Nov 30
Reports and events: 114 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1310:21 ET | 10-Q | Quarterly reportPeriod 2026-08-31 | 0001549595-26-000049 |
| 2026-10-1310:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001549595-26-000048 |
| 2026-07-0920:12 ET | 10-Q | Quarterly reportPeriod 2026-05-31 | 0001549595-26-000040 |
| 2026-07-0920:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001549595-26-000038 |
| 2026-06-1111:06 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001549595-26-000034 |
| 2026-06-0810:11 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001549595-26-000030 |
| 2026-05-1520:03 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001549595-26-000028 |
| 2026-04-0810:03 ET | 10-Q | Quarterly reportPeriod 2026-02-28 | 0001549595-26-000025 |
| 2026-04-0810:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001549595-26-000024 |
| 2026-03-2710:03 ET | DEF 14A | Proxy statementPeriod 2026-05-15 | 0001140361-26-011492 |
| 2026-03-0621:40 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-096734 |
| 2026-01-2821:09 ET | 10-K | Annual reportPeriod 2025-11-30 | 0001549595-26-000016 |
| 2026-01-2821:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001549595-26-000013 |
| 2026-01-1213:34 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001549595-26-000003 |
| 2025-12-0911:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001549595-25-000121 |
| 2025-11-1012:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001549595-25-000117 |
| 2025-10-2220:58 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-246964 |
| 2025-10-2213:04 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001549595-25-000115 |
| 2025-10-0920:04 ET | 10-Q | Quarterly reportPeriod 2025-08-31 | 0001549595-25-000113 |
| 2025-10-0920:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001549595-25-000112 |
| 2025-09-0312:06 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001549595-25-000108 |
| 2025-08-2220:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001549595-25-000105 |
| 2025-07-0920:03 ET | 10-Q | Quarterly reportPeriod 2025-05-31 | 0001549595-25-000095 |
| 2025-07-0920:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001549595-25-000094 |
| 2025-06-1212:02 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001549595-25-000086 |
| 2025-05-1920:08 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001549595-25-000067 |
| 2025-04-0820:06 ET | 10-Q | Quarterly reportPeriod 2025-02-28 | 0001549595-25-000055 |
| 2025-04-0820:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001549595-25-000053 |
| 2025-03-2810:03 ET | DEF 14A | Proxy statementPeriod 2025-05-19 | 0001140361-25-010808 |
| 2025-03-1320:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001549595-25-000043 |
| 2025-01-2821:15 ET | 10-K | Annual reportPeriod 2024-11-30 | 0001549595-25-000016 |
| 2025-01-2821:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001549595-25-000014 |
| 2025-01-1312:02 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001549595-25-000005 |
| 2024-12-1011:54 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001549595-24-000160 |
| 2024-10-3120:12 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-248678 |
| 2024-10-1620:41 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001549595-24-000138 |
| 2024-10-1120:05 ET | 10-Q | Quarterly reportPeriod 2024-08-31 | 0001549595-24-000131 |
| 2024-10-1120:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001549595-24-000130 |
| 2024-09-0511:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001549595-24-000120 |
| 2024-07-1120:07 ET | 10-Q | Quarterly reportPeriod 2024-05-31 | 0001549595-24-000098 |
| 2024-07-1120:03 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001549595-24-000097 |
| 2024-06-1711:02 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001549595-24-000086 |
| 2024-05-2111:06 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001549595-24-000073 |
| 2024-04-1221:12 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-094875 |
| 2024-04-1011:06 ET | 10-Q | Quarterly reportPeriod 2024-02-29 | 0001549595-24-000049 |
| 2024-04-1011:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001549595-24-000048 |
| 2024-04-0917:17 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001549595-24-000041 |
| 2024-03-2711:01 ET | DEF 14A | Proxy statementPeriod 2024-05-20 | 0001140361-24-015447 |
| 2024-03-1111:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001549595-24-000038 |
| 2024-02-1521:04 ET | 10-K | Annual reportPeriod 2023-11-30 | 0001549595-24-000025 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:13 ET. Listed shows no prices and gives no investment advice.